SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.01.15 | Roche kaufen | Morgan Stanley | |
| 20.01.15 | Novartis neutral | Independent Research GmbH | |
| 19.01.15 | Roche kaufen | Independent Research GmbH | |
| 19.01.15 | Roche Hold | Kepler Cheuvreux | |
| 19.01.15 | Novartis buy | Kepler Cheuvreux | |
| 16.01.15 | Roche Hold | S&P Capital IQ | |
| 16.01.15 | Novartis buy | UBS AG | |
| 16.01.15 | Roche Neutral | UBS AG | |
| 16.01.15 | Novartis buy | Jefferies & Company Inc. | |
| 16.01.15 | Roche buy | Jefferies & Company Inc. | |
| 16.01.15 | Novartis buy | S&P Capital IQ | |
| 16.01.15 | Roche overweight | Barclays Capital | |
| 16.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 15.01.15 | Novartis Hold | Deutsche Bank AG | |
| 15.01.15 | Roche buy | Deutsche Bank AG | |
| 14.01.15 | Roche overweight | JP Morgan Chase & Co. | |
| 09.01.15 | Roche Neutral | UBS AG | |
| 05.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.01.15 | Roche overweight | JP Morgan Chase & Co. | |
| 22.12.14 | Roche Outperform | BNP PARIBAS | |
| 22.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.12.14 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.12.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 12.12.14 | Novartis buy | UBS AG | |
| 11.12.14 | Roche buy | UBS AG | |
| 10.12.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.12.14 | Roche overweight | JP Morgan Chase & Co. | |
| 09.12.14 | Roche buy | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 08.12.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 03.12.14 | BB Biotech Verkaufen | Independent Research GmbH | |
| 03.12.14 | Roche overweight | Morgan Stanley | |
| 03.12.14 | Novartis Equal-Weight | Morgan Stanley | |
| 28.11.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.11.14 | Roche Outperform | BNP PARIBAS | |
| 25.11.14 | Novartis Outperform | BNP PARIBAS | |
| 13.11.14 | Roche buy | UBS AG |